ReP USP - Resultado da busca

Artigo de periodico
BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia (2023)
Brumatti, Gabriela ; Kaloni, Deeksha ; Castro, Fabíola Attié de ; Amarante-Mendes, João Gustavo Pessini
Fonte: Biochemical Journal. Unidades: FCFRP, ICB
Assuntos: IMUNOLOGIA, LEUCEMIA MIELOIDE AGUDA, NEOPLASIAS POR TIPO HISTOLÓGICO, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRUMATTI, Gabriela et al. BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia. Biochemical Journal, v. 480, p. 161–176, 2023Tradução . . Disponível em: https://doi.org/10.1042/BCJ20210608. Acesso em: 14 jul. 2024.
APA
Brumatti, G., Kaloni, D., Castro, F. A. de, & Amarante-Mendes, J. G. P. (2023). BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia. Biochemical Journal, 480, 161–176. doi:10.1042/BCJ20210608
NLM
Brumatti G, Kaloni D, Castro FA de, Amarante-Mendes JGP. BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia [Internet]. Biochemical Journal. 2023 ; 480 161–176.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1042/BCJ20210608
Vancouver
Brumatti G, Kaloni D, Castro FA de, Amarante-Mendes JGP. BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia [Internet]. Biochemical Journal. 2023 ; 480 161–176.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1042/BCJ20210608
Artigo de periodico-carta/editorial
Editorial: Women in molecular and cellular oncology (2023)
Ferrao, Petranel T. ; Rosanò, Laura ; Poli, Valeria ; Dhar, Shilpa S. ; Lepique, Ana Paula
Fonte: Frontiers in Oncology. Unidade: ICB
Assuntos: ONCOLOGIA, MULHERES NA CIÊNCIA, ENSAIO CLÍNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRAO, Petranel T. et al. Editorial: Women in molecular and cellular oncology. Frontiers in Oncology. Lausanne: Frontiers Research Foundation. Disponível em: https://doi.org/10.3389/fonc.2023.1257780. Acesso em: 14 jul. 2024. , 2023
APA
Ferrao, P. T., Rosanò, L., Poli, V., Dhar, S. S., & Lepique, A. P. (2023). Editorial: Women in molecular and cellular oncology. Frontiers in Oncology. Lausanne: Frontiers Research Foundation. doi:10.3389/fonc.2023.1257780
NLM
Ferrao PT, Rosanò L, Poli V, Dhar SS, Lepique AP. Editorial: Women in molecular and cellular oncology [Internet]. Frontiers in Oncology. 2023 ; 13 4 .[citado 2024 jul. 14 ] Available from: https://doi.org/10.3389/fonc.2023.1257780
Vancouver
Ferrao PT, Rosanò L, Poli V, Dhar SS, Lepique AP. Editorial: Women in molecular and cellular oncology [Internet]. Frontiers in Oncology. 2023 ; 13 4 .[citado 2024 jul. 14 ] Available from: https://doi.org/10.3389/fonc.2023.1257780
Artigo de periodico
Vaccines against emerging and neglected infectious diseases: an overview (2022)
Vuitika, Larissa ; Syed, Wasim Aluísio Prates ; Silva, Jaqueline Dinis Queiros; Crema, Karin Paola ; Oliveira, Nelson Côrtes de ; Lira, Aline Aparecida de lima ; Lima, Julia Beatriz Menuci ; Câmara, Niels Olsen Saraiva ; Schimke, Lena Friederike ; Marques, Otavio Cabral ; Sadraeian, Mohammad ; Chaves, Lorena C. S. ; Miranda, Gustavo Cabral de
Fonte: Vaccines. Unidades: ICB, BIOTECNOLOGIA
Assuntos: IMUNOLOGIA, VACINAS, DOENÇAS INFECCIOSAS, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VUITIKA, Larissa et al. Vaccines against emerging and neglected infectious diseases: an overview. Vaccines, v. 10, n. 9, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.3390/vaccines10091385. Acesso em: 14 jul. 2024.
APA
Vuitika, L., Syed, W. A. P., Silva, J. D. Q., Crema, K. P., Oliveira, N. C. de, Lira, A. A. de lima, et al. (2022). Vaccines against emerging and neglected infectious diseases: an overview. Vaccines, 10( 9), 1-11. doi:10.3390/vaccines10091385
NLM
Vuitika L, Syed WAP, Silva JDQ, Crema KP, Oliveira NC de, Lira AA de lima, Lima JBM, Câmara NOS, Schimke LF, Marques OC, Sadraeian M, Chaves LCS, Miranda GC de. Vaccines against emerging and neglected infectious diseases: an overview [Internet]. Vaccines. 2022 ; 10( 9): 1-11.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/vaccines10091385
Vancouver
Vuitika L, Syed WAP, Silva JDQ, Crema KP, Oliveira NC de, Lira AA de lima, Lima JBM, Câmara NOS, Schimke LF, Marques OC, Sadraeian M, Chaves LCS, Miranda GC de. Vaccines against emerging and neglected infectious diseases: an overview [Internet]. Vaccines. 2022 ; 10( 9): 1-11.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/vaccines10091385
Artigo de periodico
BCR-ABL1 Tyrosine kinase complex signaling transduction: challenges to overcome resistance in chronic myeloid Leukemia (2022)
Amarante-Mendes, João Gustavo Pessini ; Rana, Aamir ; Datoguia, Tarcila Santos ; Hamerschlak, Nelson ; Brumatti, Gabriela
Fonte: Pharmaceutics. Unidade: ICB
Assuntos: IMUNOLOGIA, TRANSDUÇÃO DE SINAL CELULAR, CROMOSSOMOS, MUTAÇÃO GENÉTICA, LEUCEMIA MIELOIDE, QUIMIOTERAPIA, AMINOÁCIDOS, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARANTE-MENDES, João Gustavo Pessini et al. BCR-ABL1 Tyrosine kinase complex signaling transduction: challenges to overcome resistance in chronic myeloid Leukemia. Pharmaceutics, v. 14, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14010215. Acesso em: 14 jul. 2024.
APA
Amarante-Mendes, J. G. P., Rana, A., Datoguia, T. S., Hamerschlak, N., & Brumatti, G. (2022). BCR-ABL1 Tyrosine kinase complex signaling transduction: challenges to overcome resistance in chronic myeloid Leukemia. Pharmaceutics, 14( 1). doi:10.3390/pharmaceutics14010215
NLM
Amarante-Mendes JGP, Rana A, Datoguia TS, Hamerschlak N, Brumatti G. BCR-ABL1 Tyrosine kinase complex signaling transduction: challenges to overcome resistance in chronic myeloid Leukemia [Internet]. Pharmaceutics. 2022 ; 14( 1):[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/pharmaceutics14010215
Vancouver
Amarante-Mendes JGP, Rana A, Datoguia TS, Hamerschlak N, Brumatti G. BCR-ABL1 Tyrosine kinase complex signaling transduction: challenges to overcome resistance in chronic myeloid Leukemia [Internet]. Pharmaceutics. 2022 ; 14( 1):[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/pharmaceutics14010215
Artigo de periodico
Recessive NLRC4-autoinflammatory disease reveals an ulcerative colitis locus (2021)
Steiner, Annemarie; Reygaerts, Thomas ; Pontillo, Alessandra ; Ceccherini, Isabella ; Moecking, Jonas ; Moghaddas, Fiona ; Davidson, Sophia ; Caroli, Francesco ; Grossi, Alice ; Castro, Fabio Fernandes Morato ; Kalil Filho, Jorge Elias ; Gohr, Florian N. ; Schmidt, Florian I.; Bartok, Eva ; Zillinger, Thomas ; Hartmann, Gunther ; Geyer, Matthias ; Gattorno, Marco ; Mendonça, Leonardo Oliveira ; Masters, Seth L.
Fonte: Journal of Clinical Immunology. Unidades: ICB, FM
Assuntos: IMUNOLOGIA, COLITE ULCERATIVA, DOENÇAS DO SISTEMA DIGESTÓRIO, INFLAMAÇÃO, COMPLEXOS MULTIENZIMÁTICOS, MACRÓFAGOS, ENTEROPATIAS, SEQUÊNCIA DO DNA, MUTAÇÃO GENÉTICA, EXONS, ATIVAÇÃO ENZIMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STEINER, Annemarie et al. Recessive NLRC4-autoinflammatory disease reveals an ulcerative colitis locus. Journal of Clinical Immunology, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.1007/s10875-021-01175-4. Acesso em: 14 jul. 2024.
APA
Steiner, A., Reygaerts, T., Pontillo, A., Ceccherini, I., Moecking, J., Moghaddas, F., et al. (2021). Recessive NLRC4-autoinflammatory disease reveals an ulcerative colitis locus. Journal of Clinical Immunology, 1-11. doi:10.1007/s10875-021-01175-4
NLM
Steiner A, Reygaerts T, Pontillo A, Ceccherini I, Moecking J, Moghaddas F, Davidson S, Caroli F, Grossi A, Castro FFM, Kalil Filho JE, Gohr FN, Schmidt FI, Bartok E, Zillinger T, Hartmann G, Geyer M, Gattorno M, Mendonça LO, Masters SL. Recessive NLRC4-autoinflammatory disease reveals an ulcerative colitis locus [Internet]. Journal of Clinical Immunology. 2021 ; 1-11.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1007/s10875-021-01175-4
Vancouver
Steiner A, Reygaerts T, Pontillo A, Ceccherini I, Moecking J, Moghaddas F, Davidson S, Caroli F, Grossi A, Castro FFM, Kalil Filho JE, Gohr FN, Schmidt FI, Bartok E, Zillinger T, Hartmann G, Geyer M, Gattorno M, Mendonça LO, Masters SL. Recessive NLRC4-autoinflammatory disease reveals an ulcerative colitis locus [Internet]. Journal of Clinical Immunology. 2021 ; 1-11.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1007/s10875-021-01175-4
Artigo de periodico
VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants (2021)
Syed, Wasim Aluisio Prates ; Chaves, Lorena C. S. ; Crema, Karin Paola; Vuitika, Larissa; Lira, Aline ; Cortês, Nelson de Angelis ; Kersten, Victor; Guimarães, Francisco Eduardo Gontijo ; Sadraeian, Mohammad ; Silva, Fernando Luís Barroso da ; Cabral-Marques, Otávio ; Barbuto, José Alexandre Marzagão ; Russo, Momtchilo ; Câmara, Niels Olsen Saraiva ; Miranda, Gustavo Cabral de
Fonte: Vaccines. Unidades: IFSC, FCFRP, ICB, BIOTECNOLOGIA
Assuntos: COVID-19, CORONAVIRUS, VACINAS VIRAIS, IMUNOLOGIA, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SYED, Wasim Aluisio Prates et al. VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants. Vaccines, v. 9, n. 12, p. 1409-1-1409-17, 2021Tradução . . Disponível em: https://doi.org/10.3390/vaccines9121409. Acesso em: 14 jul. 2024.
APA
Syed, W. A. P., Chaves, L. C. S., Crema, K. P., Vuitika, L., Lira, A., Cortês, N. de A., et al. (2021). VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants. Vaccines, 9( 12), 1409-1-1409-17. doi:10.3390/vaccines9121409
NLM
Syed WAP, Chaves LCS, Crema KP, Vuitika L, Lira A, Cortês N de A, Kersten V, Guimarães FEG, Sadraeian M, Silva FLB da, Cabral-Marques O, Barbuto JAM, Russo M, Câmara NOS, Miranda GC de. VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants [Internet]. Vaccines. 2021 ; 9( 12): 1409-1-1409-17.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/vaccines9121409
Vancouver
Syed WAP, Chaves LCS, Crema KP, Vuitika L, Lira A, Cortês N de A, Kersten V, Guimarães FEG, Sadraeian M, Silva FLB da, Cabral-Marques O, Barbuto JAM, Russo M, Câmara NOS, Miranda GC de. VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants [Internet]. Vaccines. 2021 ; 9( 12): 1409-1-1409-17.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/vaccines9121409
Artigo de periodico
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021)
Bastard, Paul ; Gervais, Adrian ; Voyer, Tom Le ; Rosain, Jérémie ; Philippot, Quentin; Manry, Jérémy ; Michailidis, Eleftherios ; Hoffmann, Hans-Heinrich ; Eto, Shohei; Garcia-Prat, Marina; Bizien, Lucy; Parra-Martínez, Alba; Yang, Rui; Liis, Haljasmägi; Migaud, Mélanie; Särekannu, Karita; Maslovskaja, Julia; Prost, Nicolas de; Tandjaoui-Lambiotte, Yacine; Luyt , Charles-Edouard; Amador-Borrero, Blanca; Alexandre, Gaudet; Poissy, Julien; Morel, Pascal; Richard, Pascale; Cognasse, Fabrice; Troya, Jesus; Trouillet-Assant, Sophie; Belot, Alexandre; Saker, Kahina; Garçon, Pierre; Rivière, Jacques G; Lagier, Jean-Christophe; Gentile, Stéphanie; Rosen, Lindsey B; Shaw, Elana; Morio, Tomohiro; Tanaka, Junko; Dalmau, David; Tharaux, Pierre-Louis; Sene, Damien; Stepanian, Alain; Megarbane, Bruno; Triantafyllia, Vasiliki; Fekkar, Arnaud; Heath, James R; Franco, José Luis; Anaya, Juan-Manuel; Solé-Violán, Jordi; Imberti, Luisa; Biondi, Andrea; Bonfanti, Paolo; Castagnoli, Riccardo; Delmonte, Ottavia M; Zhang, Yu; Snow, Andrew L; Holland, Steven M; Biggs, Catherine M; Moncada-Vélez, Marcela; Arias, Andrés Augusto; Lorenzo, Lazaro; Boucherit, Soraya; Coulibaly, Boubacar; Anglicheau, Dany; Planas, Anna M; Haerynck, Filomeen; Duvlis, Sotirija; Nussbaum, Robert L; Ozcelik, Tayfun; Keles, Sevgi; Bousfiha, Ahmed A; ElBakkouri, Jalila; Ramirez-Santana, Carolina; Paul, Stéphane; Pan-Hammarström, Qiang; Hammarström, Lennart; Dupont, Annabelle; Kurolap, Alina; Metz, Christine N; Aiuti, Alessandro; Casari, Giorgio; Lampasona, Vito; Ciceri, Fabio; Barreiros, Lucila A; Dominguez-Garrido, Elena; Vidigal, Mateus; Zatz, Mayana ; Beek, Diederik van de; Sahanic, Sabina; Tancevski, Ivan; Stepanovskyy, Yurii; Boyarchuk, Oksana; Nukui, Yoko; Tsumura, Miyuki; Vidaur, Loreto; Tangye, Stuart G; Burrel, Sonia; Duffy, Darragh; Quintana-Murci, Lluis; Klocperk, Adam; Kann, Nelli Y; Shcherbina, Anna; Lau, Yu-Lung; Leung, Daniel; Coulongeat, Matthieu; Marlet, Julien; Koning, Rutger; Reyes, Luis Felipe; Chauvineau-Grenier, Angélique; Vene, Fabienne; Monneret, Guillaume; Nussenzweig, Michel C; Arrestier, Romain; Boudhabhay, Idris; Baris-Feldman, Hagit; Hagin, David; Wauters, Joost; Meyts, Isabelle; Dyer, Adam H; Kennelly, Sean P; Bourke, Nollaig M; Halwani, Rabih; Sharif-Askari, Narjes Saheb; Dorgham, Karim; Sallette, Jérome; Sedkaoui, Souad Mehlal; AlKhater, Suzan; Rigo-Bonnin, Raúl; Morandeira, Francisco; Roussel, Lucie; Vinh, Donald C; Ostrowski, Sisse Rye; Condino Neto, Antonio ; Prando, Carolina ; Bondarenko, Anastasiia; Spaan, András N; Gilardin, Laurent; Fellay, Jacques; Lyonnet, Stanislas; Bilguvar, Kaya; Lifton, Richard P; Mane, Shrikant; Anderson, Mark S; Boisson, Bertrand; Béziat, Vivien; Zhang, Shen-Ying; Andreakos, Evangelos; Hermine, Olivier; Pujol, Aurora; Peterson, Pärt; Mogensen, Trine; H Rowen, Lee; Mond, James; Debette, Stéphanie; Lamballerie, Xavier de; Duval, Xavier; Mentré, France; Zins, Marie; Soler-Palacin, Pere; Colobran, Roger; Gorochov, Guy; Solanich, Xavier; Susen, Sophie; Martinez-Picado, Javier; Raoult, Didier; Vasse, Marc; Gregersen, Peter K; Piemonti, Lorenzo; Rodríguez-Gallego, Carlos; Notarangelo, Luigi D; Su, Helen C; Kisand, Kai; Okada, Satoshi; Puel, Anne; Jouanguy, Emmanuelle; Rice, Charles M; Tiberghien, Pierre; Zhang, Qian; Cobat, Aurélie; Abel, Laurent; Casanova, Jean-Laurent
Fonte: Science Immunology. Unidades: IB, ICB
Assuntos: COVID-19, INFECÇÕES POR CORONAVIRUS, ANTICORPOS, IMUNOLOGIA, HOMENS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTARD, Paul et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, v. 6, n. 62, p. 1-30, 2021Tradução . . Disponível em: https://doi.org/10.1126/sciimmunol.abl4340. Acesso em: 14 jul. 2024.
APA
Bastard, P., Gervais, A., Voyer, T. L., Rosain, J., Philippot, Q., Manry, J., et al. (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, 6( 62), 1-30. doi:10.1126/sciimmunol.abl4340
NLM
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Vancouver
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Artigo de periodico-carta/editorial
Editorial: Primary Immunodeficiencies Worldwide (2020)
Zelm, Menno C. van ; Condino-Neto, Antonio ; Barbouche, Mohamed-Ridha
Fonte: Frontiers in Immunology. Unidade: ICB
Assuntos: IMUNOLOGIA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZELM, Menno C. van e CONDINO-NETO, Antonio e BARBOUCHE, Mohamed-Ridha. Editorial: Primary Immunodeficiencies Worldwide. Frontiers in Immunology. Lausanne: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fimmu.2019.03148. Acesso em: 14 jul. 2024. , 2020
APA
Zelm, M. C. van, Condino-Neto, A., & Barbouche, M. -R. (2020). Editorial: Primary Immunodeficiencies Worldwide. Frontiers in Immunology. Lausanne: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.3389/fimmu.2019.03148
NLM
Zelm MC van, Condino-Neto A, Barbouche M-R. Editorial: Primary Immunodeficiencies Worldwide [Internet]. Frontiers in Immunology. 2020 ; 10 2 .[citado 2024 jul. 14 ] Available from: https://doi.org/10.3389/fimmu.2019.03148
Vancouver
Zelm MC van, Condino-Neto A, Barbouche M-R. Editorial: Primary Immunodeficiencies Worldwide [Internet]. Frontiers in Immunology. 2020 ; 10 2 .[citado 2024 jul. 14 ] Available from: https://doi.org/10.3389/fimmu.2019.03148
Artigo de periodico
Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2 (2020)
Fachi, José Luís ; Silva, Cristiane Sécca da ; Rodrigues, Patrícia Brito; Mato, Felipe Cézar Pinheiro de ; Luccia, Blanda Di ; Felipe, Jaqueline de Souza; Pral, Laís Passariello ; Oliveira, Marcella Rungue ; Rocha, Victor de Melo; Sato, Fabio Takeo ; Sampaio, Ulliana ; Clerici, Maria Teresa Pedrosa Silva ; Rodrigues, Hosana Gomes ; Câmara, Niels Olsen Saraiva ; Consonni, Sílvio Roberto ; Vieira, Angélica Thomaz ; Oliveira, Sergio Costa; Mackay, Charles Reay ; Layden, Brian T. ; Bortoluci, Karina Ramalho ; Colonna, Marco ; Vinolo, Marco Aurélio Ramirez
Fonte: Journal of Experimental Medicine. Unidade: ICB
Assuntos: IMUNOLOGIA, NEUTRÓFILOS, ANTIBIÓTICOS, CLOSTRIDIUM, DIARREIA, COLITE, METABÓLITOS, ÁCIDOS GRAXOS, RATOS, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FACHI, José Luís et al. Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2. Journal of Experimental Medicine, v. 217, n. 3, p. 29 , 2020Tradução . . Disponível em: https://doi.org/10.1084/jem.20190489. Acesso em: 14 jul. 2024.
APA
Fachi, J. L., Silva, C. S. da, Rodrigues, P. B., Mato, F. C. P. de, Luccia, B. D., Felipe, J. de S., et al. (2020). Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2. Journal of Experimental Medicine, 217( 3), 29 . doi:10.1084/jem.20190489
NLM
Fachi JL, Silva CS da, Rodrigues PB, Mato FCP de, Luccia BD, Felipe J de S, Pral LP, Oliveira MR, Rocha V de M, Sato FT, Sampaio U, Clerici MTPS, Rodrigues HG, Câmara NOS, Consonni SR, Vieira AT, Oliveira SC, Mackay CR, Layden BT, Bortoluci KR, Colonna M, Vinolo MAR. Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2 [Internet]. Journal of Experimental Medicine. 2020 ; 217( 3): 29 .[citado 2024 jul. 14 ] Available from: https://doi.org/10.1084/jem.20190489
Vancouver
Fachi JL, Silva CS da, Rodrigues PB, Mato FCP de, Luccia BD, Felipe J de S, Pral LP, Oliveira MR, Rocha V de M, Sato FT, Sampaio U, Clerici MTPS, Rodrigues HG, Câmara NOS, Consonni SR, Vieira AT, Oliveira SC, Mackay CR, Layden BT, Bortoluci KR, Colonna M, Vinolo MAR. Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2 [Internet]. Journal of Experimental Medicine. 2020 ; 217( 3): 29 .[citado 2024 jul. 14 ] Available from: https://doi.org/10.1084/jem.20190489
Artigo de periodico
Flow cytometry contributions for the diagnosis and immunopathological characterization of primary immunodeficiency diseases with immune dysregulation (2019)
Marques, Otavio Cabral ; Schimke, Lena Friederike; Oliveira Junior, Edgar Borges de ; Khawanky, Nadia El ; Ramos, Rodrigo Nalio; Al-Ramadi, Basel K. ; Segundo, Gesmar Rodrigues Silva ; Ochs, Hans D.; Condino Neto, Antonio
Fonte: Frontiers in Immunology. Unidade: ICB
Assuntos: IMUNOLOGIA, CITOMETRIA DE FLUXO, DOENÇAS IMUNOLÓGICAS, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, MUTAÇÃO GENÉTICA, SEQUENCIAMENTO GENÉTICO, GENOMAS, FENÓTIPOS, AUTOIMUNIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARQUES, Otavio Cabral et al. Flow cytometry contributions for the diagnosis and immunopathological characterization of primary immunodeficiency diseases with immune dysregulation. Frontiers in Immunology, v. 10, p. 23 , 2019Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2019.02742. Acesso em: 14 jul. 2024.
APA
Marques, O. C., Schimke, L. F., Oliveira Junior, E. B. de, Khawanky, N. E., Ramos, R. N., Al-Ramadi, B. K., et al. (2019). Flow cytometry contributions for the diagnosis and immunopathological characterization of primary immunodeficiency diseases with immune dysregulation. Frontiers in Immunology, 10, 23 . doi:10.3389/fimmu.2019.02742
NLM
Marques OC, Schimke LF, Oliveira Junior EB de, Khawanky NE, Ramos RN, Al-Ramadi BK, Segundo GRS, Ochs HD, Condino Neto A. Flow cytometry contributions for the diagnosis and immunopathological characterization of primary immunodeficiency diseases with immune dysregulation [Internet]. Frontiers in Immunology. 2019 ;10 23 .[citado 2024 jul. 14 ] Available from: https://doi.org/10.3389/fimmu.2019.02742
Vancouver
Marques OC, Schimke LF, Oliveira Junior EB de, Khawanky NE, Ramos RN, Al-Ramadi BK, Segundo GRS, Ochs HD, Condino Neto A. Flow cytometry contributions for the diagnosis and immunopathological characterization of primary immunodeficiency diseases with immune dysregulation [Internet]. Frontiers in Immunology. 2019 ;10 23 .[citado 2024 jul. 14 ] Available from: https://doi.org/10.3389/fimmu.2019.02742
Artigo de periodico
X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world (2019)
El-Sayed, Zeinab A. ; Abramova, Irina ; Aldave, Juan Carlos ; Al-Herz, Waleed ; Bezrodnik, Liliana ; Boukari, Rachida ; Bousfilha, Ahmed Aziz; Cancrini, Caterina ; Dbaibo, Ghassan ; Derfalvi, Beata; Dogu, Figen ; Edgar, J. Davi M.; Eley, Brian ; El-Owaidy, Rasha Hasan ; Espinosa-Padilla, Sara Elva; Galal, Nermeen ; Haerynck, Filomeen ; Hanna-Wakim, Rima ; Hossny, Elham ; Ikinciogullari, Aydan ; Kamal, Ebtihal; Kanegane, Hirokaku ; Kechout, Nadia ; Lau, Yu Lung ; Morio, Tomohiro; Moschese, Viviana ; Neves, João Farela ; Quederni, Monia; Paganelli, Roberto ; Paris, Kenneth ; Pignata, Claudia; Plebani, Alessandro ; Qamar, Farah Naz; Qureshi, Sonia ; Radhakrishnan, Nita ; Rezaei, Nima; Rosario, Nelson ; Routes, John ; Sanchez, Berta; Sediva, Anna ; Seppanen, Mikko Risto Juhana ; Serrano, Edith Gonzalez ; Shcherbina, Anna ; Singh, Surjit ; Siniah, Sangeetha; Spadaro, Guiseppe; Tang, Mimi ; Vinet, Ana Maria; Volokha, Alla ; Sullivan, Kathleen E. ; Condino Neto, Antonio
Fonte: World Allergy Organization Journal. Unidade: ICB
Assuntos: FENÓTIPOS, AGAMAGLOBULINEMIA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, IMUNOGLOBULINAS, GENÉTICA APLICADA, ALERGIA E IMUNOLOGIA, VACINAS, LINFÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EL-SAYED, Zeinab A. et al. X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world. World Allergy Organization Journal, v. 12, p. 9 , 2019Tradução . . Disponível em: https://doi.org/10.1016/j.waojou.2019.100018. Acesso em: 14 jul. 2024.
APA
El-Sayed, Z. A., Abramova, I., Aldave, J. C., Al-Herz, W., Bezrodnik, L., Boukari, R., et al. (2019). X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world. World Allergy Organization Journal, 12, 9 . doi:10.1016/j.waojou.2019.100018
NLM
El-Sayed ZA, Abramova I, Aldave JC, Al-Herz W, Bezrodnik L, Boukari R, Bousfilha AA, Cancrini C, Dbaibo G, Derfalvi B, Dogu F, Edgar JDM, Eley B, El-Owaidy RH, Espinosa-Padilla SE, Galal N, Haerynck F, Hanna-Wakim R, Hossny E, Ikinciogullari A, Kamal E, Kanegane H, Kechout N, Lau YL, Morio T, Moschese V, Neves JF, Quederni M, Paganelli R, Paris K, Pignata C, Plebani A, Qamar FN, Qureshi S, Radhakrishnan N, Rezaei N, Rosario N, Routes J, Sanchez B, Sediva A, Seppanen MRJ, Serrano EG, Shcherbina A, Singh S, Siniah S, Spadaro G, Tang M, Vinet AM, Volokha A, Sullivan KE, Condino Neto A. X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world [Internet]. World Allergy Organization Journal. 2019 ; 12 9 .[citado 2024 jul. 14 ] Available from: https://doi.org/10.1016/j.waojou.2019.100018
Vancouver
El-Sayed ZA, Abramova I, Aldave JC, Al-Herz W, Bezrodnik L, Boukari R, Bousfilha AA, Cancrini C, Dbaibo G, Derfalvi B, Dogu F, Edgar JDM, Eley B, El-Owaidy RH, Espinosa-Padilla SE, Galal N, Haerynck F, Hanna-Wakim R, Hossny E, Ikinciogullari A, Kamal E, Kanegane H, Kechout N, Lau YL, Morio T, Moschese V, Neves JF, Quederni M, Paganelli R, Paris K, Pignata C, Plebani A, Qamar FN, Qureshi S, Radhakrishnan N, Rezaei N, Rosario N, Routes J, Sanchez B, Sediva A, Seppanen MRJ, Serrano EG, Shcherbina A, Singh S, Siniah S, Spadaro G, Tang M, Vinet AM, Volokha A, Sullivan KE, Condino Neto A. X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world [Internet]. World Allergy Organization Journal. 2019 ; 12 9 .[citado 2024 jul. 14 ] Available from: https://doi.org/10.1016/j.waojou.2019.100018
Artigo de periodico
Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic‐ and GPR109a‐mediated mechanisms (2019)
Felizardo, Raphael José Ferreira; Almeida, Danilo Candido de ; Pereira, Rafael Luiz; Watanabe, Ingrid Kazue Mizuno; Doimo, Nayara Trevisan dos Santos; Ribeiro, Willian Rodrigues; Cenedeze, Marcos Antonio; Hiyane, Meire Ioshie; Amano, Mariane Tami ; Braga, Tárcio Teodoro ; Ferreira, Caroline Marcantonio ; Parmigiani, Raphael Bessa; Oliveira, Vinicius de Andrade ; Volpini, Rildo Aparecido ; Vinolo, Marco Aurelio Ramirez ; Moreno, Eliana Mariño ; Robert, Remy ; Mackay, Charles Reay ; Câmara, Niels Olsen Saraiva
Fonte: The FASEB Journal. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FELIZARDO, Raphael José Ferreira et al. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic‐ and GPR109a‐mediated mechanisms. The FASEB Journal, v. 33, n. 11, p. 11894-11908, 2019Tradução . . Disponível em: https://doi.org/10.1096/fj.201901080R. Acesso em: 14 jul. 2024.
APA
Felizardo, R. J. F., Almeida, D. C. de, Pereira, R. L., Watanabe, I. K. M., Doimo, N. T. dos S., Ribeiro, W. R., et al. (2019). Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic‐ and GPR109a‐mediated mechanisms. The FASEB Journal, 33( 11), 11894-11908. doi:10.1096/fj.201901080R
NLM
Felizardo RJF, Almeida DC de, Pereira RL, Watanabe IKM, Doimo NT dos S, Ribeiro WR, Cenedeze MA, Hiyane MI, Amano MT, Braga TT, Ferreira CM, Parmigiani RB, Oliveira V de A, Volpini RA, Vinolo MAR, Moreno EM, Robert R, Mackay CR, Câmara NOS. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic‐ and GPR109a‐mediated mechanisms [Internet]. The FASEB Journal. 2019 ; 33( 11): 11894-11908.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1096/fj.201901080R
Vancouver
Felizardo RJF, Almeida DC de, Pereira RL, Watanabe IKM, Doimo NT dos S, Ribeiro WR, Cenedeze MA, Hiyane MI, Amano MT, Braga TT, Ferreira CM, Parmigiani RB, Oliveira V de A, Volpini RA, Vinolo MAR, Moreno EM, Robert R, Mackay CR, Câmara NOS. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic‐ and GPR109a‐mediated mechanisms [Internet]. The FASEB Journal. 2019 ; 33( 11): 11894-11908.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1096/fj.201901080R
Artigo de periodico
Tuberculosis and impaired IL-23–dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant (2018)
Boisson-Dupuis, Stéphanie; Ramires-Alejo, Noe; Li, Zhi; Patin, Etienne; Rao, Geetha; Kerner, Gaspard; Lim, Che Kang; Krementsov, Dimitry N.; Hernandez, Nicholas; Ma, Cidy S.; Zhang, Qian; Markle, Janet; Martinez-Barricarte, Ruben; Payne, Kathryn; Fisch, Robert; Deswarte, Caroline; Halpern, Joshua; Bouaziz, Matthieu; Mulwa, Jeanette; Sivanesan, Durga; Lazarov, Tomi; Naves, Rodrigo; Garcia, Patricia; Itan, Yuval; Boisson, Bertrand; Checci, Alix; Jabot-Hanin, Fabienne; Cobat, Aurélie; Guennoun, Andrea; Jackson, Carolyn C.; Pekcan, Sevai; Caliskaner, Zafer; Inostroza, Jaime; Costa-Carvalho, Beatriz Tavares; Albuquerque, José Antonio Tavares de; Gacia-Ortiz, Humberto; Orozco, Lorena; Ozcelik, Tayfun; Abid, Ahmed; Rhorfi, Ismail Abderahmani; Souhi, Hicham; Amrani, Hicham Naji; Zegmout, Adil; Geissmann, Frédéric; Michnick, Stephen W.; Muller-Fleckenstein, Ingrid; Fleckenstein, Bernhard; Puel, Anne; Ciancanelli, Michael J.; Marr, Nico; Abolhassani, Hassan; Balcells, Maria Elvira; Strickler, Alexis; Abarca, Katia; Teuscher, Cory; Ochs, Hans D.; Reisli, Ismail; Sayar, Esra H.; El-Baghdadi, Jamila; Bustamante, Jacinta; Hammarströn, Lennart; Tangye, Stuart G.; Pellegrini, Sandra; Quintana-Murci, Lluis; Abel, Laurent; Casanova, Jean-Laurent; Condino-Neto, Antonio
Fonte: Science Immunology. Unidade: ICB
Assuntos: TUBERCULOSE, VARIAÇÃO GENÉTICA, IMUNIDADE, CITOCINAS, DIFERENCIAÇÃO CELULAR, ATIVAÇÃO ENZIMÁTICA, IMUNOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOISSON-DUPUIS, Stéphanie et al. Tuberculosis and impaired IL-23–dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant. Science Immunology, v. 3, 2018Tradução . . Disponível em: https://doi.org/10.1126/sciimmunol.aau8714. Acesso em: 14 jul. 2024.
APA
Boisson-Dupuis, S., Ramires-Alejo, N., Li, Z., Patin, E., Rao, G., Kerner, G., et al. (2018). Tuberculosis and impaired IL-23–dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant. Science Immunology, 3. doi:10.1126/sciimmunol.aau8714
NLM
Boisson-Dupuis S, Ramires-Alejo N, Li Z, Patin E, Rao G, Kerner G, Lim CK, Krementsov DN, Hernandez N, Ma CS, Zhang Q, Markle J, Martinez-Barricarte R, Payne K, Fisch R, Deswarte C, Halpern J, Bouaziz M, Mulwa J, Sivanesan D, Lazarov T, Naves R, Garcia P, Itan Y, Boisson B, Checci A, Jabot-Hanin F, Cobat A, Guennoun A, Jackson CC, Pekcan S, Caliskaner Z, Inostroza J, Costa-Carvalho BT, Albuquerque JAT de, Gacia-Ortiz H, Orozco L, Ozcelik T, Abid A, Rhorfi IA, Souhi H, Amrani HN, Zegmout A, Geissmann F, Michnick SW, Muller-Fleckenstein I, Fleckenstein B, Puel A, Ciancanelli MJ, Marr N, Abolhassani H, Balcells ME, Strickler A, Abarca K, Teuscher C, Ochs HD, Reisli I, Sayar EH, El-Baghdadi J, Bustamante J, Hammarströn L, Tangye SG, Pellegrini S, Quintana-Murci L, Abel L, Casanova J-L, Condino-Neto A. Tuberculosis and impaired IL-23–dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant [Internet]. Science Immunology. 2018 ; 3[citado 2024 jul. 14 ] Available from: https://doi.org/10.1126/sciimmunol.aau8714
Vancouver
Boisson-Dupuis S, Ramires-Alejo N, Li Z, Patin E, Rao G, Kerner G, Lim CK, Krementsov DN, Hernandez N, Ma CS, Zhang Q, Markle J, Martinez-Barricarte R, Payne K, Fisch R, Deswarte C, Halpern J, Bouaziz M, Mulwa J, Sivanesan D, Lazarov T, Naves R, Garcia P, Itan Y, Boisson B, Checci A, Jabot-Hanin F, Cobat A, Guennoun A, Jackson CC, Pekcan S, Caliskaner Z, Inostroza J, Costa-Carvalho BT, Albuquerque JAT de, Gacia-Ortiz H, Orozco L, Ozcelik T, Abid A, Rhorfi IA, Souhi H, Amrani HN, Zegmout A, Geissmann F, Michnick SW, Muller-Fleckenstein I, Fleckenstein B, Puel A, Ciancanelli MJ, Marr N, Abolhassani H, Balcells ME, Strickler A, Abarca K, Teuscher C, Ochs HD, Reisli I, Sayar EH, El-Baghdadi J, Bustamante J, Hammarströn L, Tangye SG, Pellegrini S, Quintana-Murci L, Abel L, Casanova J-L, Condino-Neto A. Tuberculosis and impaired IL-23–dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant [Internet]. Science Immunology. 2018 ; 3[citado 2024 jul. 14 ] Available from: https://doi.org/10.1126/sciimmunol.aau8714
Artigo de periodico
Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation (2017)
Morena, Maria Teresa de la ; Leonard, David; Torgerson, Troy R.; Marques, Otavio Cabral; Slatter, Mary Anne; Aghamohammadi, Asghar ; Chandra, Sharat; Favela, Luis Murguia ; Bonilla, Francisco A. ; Kanariou, Maria; Damrongwatanasuk, Rongras; Kuo, Caroline Y.; Dvorak, Christopher C. ; Meyts, Isabelle; Chen, Karin ; Kobrynski, Lisa ; Kapoor, Neena; Richter, Darko ; DiGiovanni, Daniela; Dhalla, Fatima ; Farmaki, Evangelia ; Speckmann, Carsten ; Español, Teresa; Shcherbina, Anna YU ; Hanson, Imelda Celine Guerra; Litzman, Jiri ; Routes, John M. ; Wong, Melanie; Fuleihan, Ramsay ; Seneviratne, Suranjith L. ; Small, Trudy N.; Janda, Ales ; Bezrodnik, Liliana; Seger, Reinhard; Raccio, Andrea Gomez; Edgar, John David M. ; Chou, Janet ; Abbott, Jordan Keith ; Montfrans, Joris van ; Granado, Luis Ignacio González ; Bunin, Nancy; Kutukculer, Necil ; Gray, Paul ; Seminario, Gisela; Pasic, Srdjan ; Aquino, Victor; Wysocki, Christian ; Abolhassani, Hassan ; Dorsey, Morna ; Rundles, Charlotte Cunningham ; Knutsen, Alan Paul ; Sleasman, John William ; Carvalho, Beatriz Tavares Costa ; Condino-Neto, Antonio ; Grunebaum, Eyal ; Chapel, Helen ; Ochs, Hans Dieter; Filipovich, Alexandra Hult; Cowan, Mort; Gennery, Andrew ; Cant, Andrew James ; Notarangelo, Luigi D. ; Roifman, Chaim M.
Fonte: Journal of Allergy and Clinical Immunology. Unidade: ICB
Assuntos: IMUNOLOGIA, CÉLULAS-TRONCO, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, HEMATOPOESE, CÉLULAS SANGUÍNEAS, IMUNOLOGIA CELULAR, DOENÇAS AUTOIMUNES, DOENÇAS IMUNOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENA, Maria Teresa de la et al. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. Journal of Allergy and Clinical Immunology, v. 139, n. 4, p. 1282-1292, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.jaci.2016.07.039. Acesso em: 14 jul. 2024.
APA
Morena, M. T. de la, Leonard, D., Torgerson, T. R., Marques, O. C., Slatter, M. A., Aghamohammadi, A., et al. (2017). Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. Journal of Allergy and Clinical Immunology, 139( 4), 1282-1292. doi:10.1016/j.jaci.2016.07.039
NLM
Morena MT de la, Leonard D, Torgerson TR, Marques OC, Slatter MA, Aghamohammadi A, Chandra S, Favela LM, Bonilla FA, Kanariou M, Damrongwatanasuk R, Kuo CY, Dvorak CC, Meyts I, Chen K, Kobrynski L, Kapoor N, Richter D, DiGiovanni D, Dhalla F, Farmaki E, Speckmann C, Español T, Shcherbina AYU, Hanson ICG, Litzman J, Routes JM, Wong M, Fuleihan R, Seneviratne SL, Small TN, Janda A, Bezrodnik L, Seger R, Raccio AG, Edgar JDM, Chou J, Abbott JK, Montfrans J van, Granado LIG, Bunin N, Kutukculer N, Gray P, Seminario G, Pasic S, Aquino V, Wysocki C, Abolhassani H, Dorsey M, Rundles CC, Knutsen AP, Sleasman JW, Carvalho BTC, Condino-Neto A, Grunebaum E, Chapel H, Ochs HD, Filipovich AH, Cowan M, Gennery A, Cant AJ, Notarangelo LD, Roifman CM. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation [Internet]. Journal of Allergy and Clinical Immunology. 2017 ; 139( 4): 1282-1292.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1016/j.jaci.2016.07.039
Vancouver
Morena MT de la, Leonard D, Torgerson TR, Marques OC, Slatter MA, Aghamohammadi A, Chandra S, Favela LM, Bonilla FA, Kanariou M, Damrongwatanasuk R, Kuo CY, Dvorak CC, Meyts I, Chen K, Kobrynski L, Kapoor N, Richter D, DiGiovanni D, Dhalla F, Farmaki E, Speckmann C, Español T, Shcherbina AYU, Hanson ICG, Litzman J, Routes JM, Wong M, Fuleihan R, Seneviratne SL, Small TN, Janda A, Bezrodnik L, Seger R, Raccio AG, Edgar JDM, Chou J, Abbott JK, Montfrans J van, Granado LIG, Bunin N, Kutukculer N, Gray P, Seminario G, Pasic S, Aquino V, Wysocki C, Abolhassani H, Dorsey M, Rundles CC, Knutsen AP, Sleasman JW, Carvalho BTC, Condino-Neto A, Grunebaum E, Chapel H, Ochs HD, Filipovich AH, Cowan M, Gennery A, Cant AJ, Notarangelo LD, Roifman CM. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation [Internet]. Journal of Allergy and Clinical Immunology. 2017 ; 139( 4): 1282-1292.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1016/j.jaci.2016.07.039
Artigo de periodico
Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery (2016)
Scott, Eric M.; Halees, A.; Itan, Y.; Spencer, E. G.; He,Y.; Azab, M. A.; Gabriel, S. B.; Belkadi, A.; Boisson, B.; Abel, L.; Clark, A. G.; Consortium, Greater Middle East Variome; Alkuraya, F. S.; Casanova, J. L.; Gleeson, J. G.; Rahim, S. A.; Abdel-Hadi, S.; Abdel-Salam, G.; Abdel-Salam, E.; Abdou, M.; Abhytankar, A.; Adimi, P.; Ahmad, J.; Akcakus, M.; Aksu, G.; Hajjar, S. A.; Juamaah, S. A.; Muhsen, S. A.; Sannaa, N. A.; Tameni, S. A.; Al-Aama, J.; Al-Allawi, N.; Al-Baradie, R.; Al-Gazali, L.; Al-Hashem, A.; Al-Herz, W.; Al-Jeaid, D.; Al-Tawari, A.; Alangari, A.; Alcais, A.; AlFawaz, T.; Alsum, Z.; Ammar-Khodja, A.; Amouian, S.; Ammar-Khodja, A.; Arikan, C.; Aryani, O.; Aslanger, A.; Aydogmus, C.; Aytekin, C.; Azam, M.; Bansagi, B.; Barbouche, M. R.; Bastaki, L.; Ben-Omran, T.; Bindu, P. S.; Blancas, L.; Boisson-Dupuis, S.; Bonnet, D.; Stambouli, O. B.; Bousfiha, A.; Boussafara, L.; Boutros, J.; Bustamante, J.; Caksen, H.; Camcioglu, Y.; Catherinot, E.; Celik, F. C.; Ciancanelli, M.; Cipe, F. E.; Clark, G.; Cobat, A.; Comu, S.; Condie, A.; Condino-Neto, A.; Desai, M.; Dobyns, W.; Dogu, F.; Domaia, M.; Egritas, O.; Azbaoui, S. E.; Baghdadi, J. E.; Ruby, M. E.; El-Harouni, A.; Elfeky,R. A.; Elghazali, G.; Faqeih, E.; Fenerci, E.; Fieschi, C.; Funda, C.; Gamal, I.; Gelik, U.; Genel, F.; Gezdirici, A.; Girisha, K. M.; Goldstein, A.; Grattan-Smith, P.; Gupta, N.; Hahn, J.; Hatipoglu, N.; Hennekam, R.; Houshmand, M.; Ichai, P.; Ikinciogullari, A.; Ismail, S.; Jalas, C.; Jouanguy, E.; Kabra, M.; Kalkan, G.; Kara, M.; Karaca, N.; Karaer, K.; Kariminejad, A.; Kayserili, H.; Keser-Emiroglu, M.; Kilic, S. S.; Kissani, N.; Kokron, C.; Koul, R.; Kutukculer, N.; Lanternier, F.; Mahdaviani, A.; Mahlaoui, N.; Mansour, L.; Mansouri, D.; Margari, L.; Valente, E. M.; Marzouki, N.; Masri, A.; Megahed, A.; Megahed, H.; Mekki, N.; Mesdaghi, M.; Mikati, M.; Mojahedi, F.; Mulley, J.; Nampoothiri, S.; Navarrete, C.; Omar, T.; Oraby, A.; Pandaluz, A.; Parvaneh, N.; Patiroglu, T.; Koc, Z. P.; Pellier, I.; Picard, C.; Puel, A.; Raas-Rothschild, A.; Rajab, A.; Raoult, D.; Reisli, I.; Rezaei, N.; Sabri, A.; Sahin, Y.; Saleem, L.; Salem, F.; AlSediq, N. S.; Sanal, O.; Sanger, T.; Shakankiry, H.; Shang, L.; Shehata, N.; Shembesh, N.; Shkalim, V.; Softah, A.; Sogaty, S.; Soliman, N.; Sonmez Aunaci, F.; Sztriha, L.; Taibi-Berrah, L.; Temtamy, S.; Tonekaboni, H.; Trauner, D.; Tuysuz, B.; Varan, A.; Vogt, G.; Walsh, C.; Woods, G.; Yesil, G.; Yildiran, A.; Yildiz, B.; Yuksel, A.; Zaki, M.; Zhang, S. Y.
Fonte: Nature Genetics. Unidade: ICB
Assuntos: VARIAÇÃO GENÉTICA, GENÉTICA, GENÉTICA DE POPULAÇÕES, IMUNOLOGIA, ALELOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCOTT, Eric M. et al. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nature Genetics, v. 48, n. 9, p. 1071-1076, 2016Tradução . . Disponível em: https://doi.org/10.1038/ng.3592. Acesso em: 14 jul. 2024.
APA
Scott, E. M., Halees, A., Itan, Y., Spencer, E. G., He, Y., Azab, M. A., et al. (2016). Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nature Genetics, 48( 9), 1071-1076. doi:10.1038/ng.3592
NLM
Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, Gabriel SB, Belkadi A, Boisson B, Abel L, Clark AG, Consortium GMEV, Alkuraya FS, Casanova JL, Gleeson JG, Rahim SA, Abdel-Hadi S, Abdel-Salam G, Abdel-Salam E, Abdou M, Abhytankar A, Adimi P, Ahmad J, Akcakus M, Aksu G, Hajjar SA, Juamaah SA, Muhsen SA, Sannaa NA, Tameni SA, Al-Aama J, Al-Allawi N, Al-Baradie R, Al-Gazali L, Al-Hashem A, Al-Herz W, Al-Jeaid D, Al-Tawari A, Alangari A, Alcais A, AlFawaz T, Alsum Z, Ammar-Khodja A, Amouian S, Ammar-Khodja A, Arikan C, Aryani O, Aslanger A, Aydogmus C, Aytekin C, Azam M, Bansagi B, Barbouche MR, Bastaki L, Ben-Omran T, Bindu PS, Blancas L, Boisson-Dupuis S, Bonnet D, Stambouli OB, Bousfiha A, Boussafara L, Boutros J, Bustamante J, Caksen H, Camcioglu Y, Catherinot E, Celik FC, Ciancanelli M, Cipe FE, Clark G, Cobat A, Comu S, Condie A, Condino-Neto A, Desai M, Dobyns W, Dogu F, Domaia M, Egritas O, Azbaoui SE, Baghdadi JE, Ruby ME, El-Harouni A, Elfeky RA, Elghazali G, Faqeih E, Fenerci E, Fieschi C, Funda C, Gamal I, Gelik U, Genel F, Gezdirici A, Girisha KM, Goldstein A, Grattan-Smith P, Gupta N, Hahn J, Hatipoglu N, Hennekam R, Houshmand M, Ichai P, Ikinciogullari A, Ismail S, Jalas C, Jouanguy E, Kabra M, Kalkan G, Kara M, Karaca N, Karaer K, Kariminejad A, Kayserili H, Keser-Emiroglu M, Kilic SS, Kissani N, Kokron C, Koul R, Kutukculer N, Lanternier F, Mahdaviani A, Mahlaoui N, Mansour L, Mansouri D, Margari L, Valente EM, Marzouki N, Masri A, Megahed A, Megahed H, Mekki N, Mesdaghi M, Mikati M, Mojahedi F, Mulley J, Nampoothiri S, Navarrete C, Omar T, Oraby A, Pandaluz A, Parvaneh N, Patiroglu T, Koc ZP, Pellier I, Picard C, Puel A, Raas-Rothschild A, Rajab A, Raoult D, Reisli I, Rezaei N, Sabri A, Sahin Y, Saleem L, Salem F, AlSediq NS, Sanal O, Sanger T, Shakankiry H, Shang L, Shehata N, Shembesh N, Shkalim V, Softah A, Sogaty S, Soliman N, Sonmez Aunaci F, Sztriha L, Taibi-Berrah L, Temtamy S, Tonekaboni H, Trauner D, Tuysuz B, Varan A, Vogt G, Walsh C, Woods G, Yesil G, Yildiran A, Yildiz B, Yuksel A, Zaki M, Zhang SY. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery [Internet]. Nature Genetics. 2016 ; 48( 9): 1071-1076.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1038/ng.3592
Vancouver
Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, Gabriel SB, Belkadi A, Boisson B, Abel L, Clark AG, Consortium GMEV, Alkuraya FS, Casanova JL, Gleeson JG, Rahim SA, Abdel-Hadi S, Abdel-Salam G, Abdel-Salam E, Abdou M, Abhytankar A, Adimi P, Ahmad J, Akcakus M, Aksu G, Hajjar SA, Juamaah SA, Muhsen SA, Sannaa NA, Tameni SA, Al-Aama J, Al-Allawi N, Al-Baradie R, Al-Gazali L, Al-Hashem A, Al-Herz W, Al-Jeaid D, Al-Tawari A, Alangari A, Alcais A, AlFawaz T, Alsum Z, Ammar-Khodja A, Amouian S, Ammar-Khodja A, Arikan C, Aryani O, Aslanger A, Aydogmus C, Aytekin C, Azam M, Bansagi B, Barbouche MR, Bastaki L, Ben-Omran T, Bindu PS, Blancas L, Boisson-Dupuis S, Bonnet D, Stambouli OB, Bousfiha A, Boussafara L, Boutros J, Bustamante J, Caksen H, Camcioglu Y, Catherinot E, Celik FC, Ciancanelli M, Cipe FE, Clark G, Cobat A, Comu S, Condie A, Condino-Neto A, Desai M, Dobyns W, Dogu F, Domaia M, Egritas O, Azbaoui SE, Baghdadi JE, Ruby ME, El-Harouni A, Elfeky RA, Elghazali G, Faqeih E, Fenerci E, Fieschi C, Funda C, Gamal I, Gelik U, Genel F, Gezdirici A, Girisha KM, Goldstein A, Grattan-Smith P, Gupta N, Hahn J, Hatipoglu N, Hennekam R, Houshmand M, Ichai P, Ikinciogullari A, Ismail S, Jalas C, Jouanguy E, Kabra M, Kalkan G, Kara M, Karaca N, Karaer K, Kariminejad A, Kayserili H, Keser-Emiroglu M, Kilic SS, Kissani N, Kokron C, Koul R, Kutukculer N, Lanternier F, Mahdaviani A, Mahlaoui N, Mansour L, Mansouri D, Margari L, Valente EM, Marzouki N, Masri A, Megahed A, Megahed H, Mekki N, Mesdaghi M, Mikati M, Mojahedi F, Mulley J, Nampoothiri S, Navarrete C, Omar T, Oraby A, Pandaluz A, Parvaneh N, Patiroglu T, Koc ZP, Pellier I, Picard C, Puel A, Raas-Rothschild A, Rajab A, Raoult D, Reisli I, Rezaei N, Sabri A, Sahin Y, Saleem L, Salem F, AlSediq NS, Sanal O, Sanger T, Shakankiry H, Shang L, Shehata N, Shembesh N, Shkalim V, Softah A, Sogaty S, Soliman N, Sonmez Aunaci F, Sztriha L, Taibi-Berrah L, Temtamy S, Tonekaboni H, Trauner D, Tuysuz B, Varan A, Vogt G, Walsh C, Woods G, Yesil G, Yildiran A, Yildiz B, Yuksel A, Zaki M, Zhang SY. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery [Internet]. Nature Genetics. 2016 ; 48( 9): 1071-1076.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1038/ng.3592

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos